Therapeutic Vaccine Shows Promise in Phase 1 Trial Against a Range of Cancers

MONDAY, Oct. 1, 2018 — A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, researchers report.
HER2-positive cancers are cancers that have too much of…
Source: Topamax